Partners Group invests USD 100 million in Silicon Ranch Corporation, a US developer, owner and operator of solar power production facilities read more
Clearside Biomedical, Inc. Announces Positive Preliminary Phase 2 Results in Patients with Macular Edema Associated with Retinal Vein Occlusion read more 04/26/16
Clinical Trial Results Show Synergy between NuSirt Technology and Metformin in Patients with Type 2 Diabetes read more 01/26/16
Clearside Biomedical, Inc. Completes Enrollment in Phase 2 Clinical Trial of CLS-TA for the Treatment of Retinal Vein Occlusion Using Suprachoroidal Space (SCS™) Drug Administration read more 12/14/15
NuSirt Biopharma Receives FDA Fast Track Designation for Non-Alcoholic Fatty Liver Disease Treatment read more 12/10/15
